https://blog.lifesciencenation.com/2026/09/01/hot-investor-mandate-cross-border-early-stage-vc-invests-150k-1m-in-techbio-and-technology-enabled-healthcare-companies/Next Phase Newsletteren2026-09-01T16:00:09+00:00Hot Investor Mandate: Cross-Border Early-Stage VC Invests $150K–$1M in TechBio and Technology-Enabled Healthcare Companiestechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/09/01/hot-investor-mandate-us-based-healthcare-focused-fund-invests-around-10m-in-companies-developing-novel-therapeutics-open-to-various-modalities/Next Phase Newsletteren2026-09-01T15:59:43+00:00Hot Investor Mandate: US-Based Healthcare Focused Fund Invests Around $10M in Companies Developing Novel Therapeutics, Open to Various Modalitiestechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/09/01/hot-investor-mandate-global-cvc-invests-1-3m-in-healthcare-and-life-sciences-companies-through-evergreen-fund/Next Phase Newsletteren2026-09-01T15:59:23+00:00Hot Investor Mandate: Global CVC Invests $1–3M in Healthcare and Life Sciences Companies Through Evergreen Fundtechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/09/01/hot-investor-mandate-vc-with-global-investment-mandate-seeks-seed-to-series-b-therapeutics-medtech-and-digital-health-companies/Next Phase Newsletteren2026-09-01T15:59:07+00:00Hot Investor Mandate: VC With Global Investment Mandate Seeks Seed to Series B Therapeutics, Medtech, and Digital Health Companiestechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence